137 related articles for article (PubMed ID: 12672615)
1. The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis.
Rinaki E; Valsami G; Macheras P
Int J Pharm; 2003 Apr; 255(1-2):199-207. PubMed ID: 12672615
[TBL] [Abstract][Full Text] [Related]
2. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
3. Diffusion in HPMC gels. II. Prediction of drug release rates from hydrophilic matrix extended-release dosage forms.
Gao P; Nixon PR; Skoug JW
Pharm Res; 1995 Jul; 12(7):965-71. PubMed ID: 7494816
[TBL] [Abstract][Full Text] [Related]
4. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).
Siepmann J; Peppas NA
Adv Drug Deliv Rev; 2001 Jun; 48(2-3):139-57. PubMed ID: 11369079
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
6. Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets.
Xu G; Sunada H
Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):483-7. PubMed ID: 7774032
[TBL] [Abstract][Full Text] [Related]
7. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer.
Ju RT; Nixon PR; Patel MV
J Pharm Sci; 1995 Dec; 84(12):1455-63. PubMed ID: 8748329
[TBL] [Abstract][Full Text] [Related]
8. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
Chen L; Wang F
Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
[TBL] [Abstract][Full Text] [Related]
9. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
Mitchell SA; Balwinski KM
J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
[TBL] [Abstract][Full Text] [Related]
10. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
Viridén A; Wittgren B; Larsson A
Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
[TBL] [Abstract][Full Text] [Related]
11. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
Ferrero C; Massuelle D; Doelker E
J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
[TBL] [Abstract][Full Text] [Related]
12. Captopril floating and/or bioadhesive tablets: design and release kinetics.
Nur AO; Zhang JS
Drug Dev Ind Pharm; 2000 Sep; 26(9):965-9. PubMed ID: 10914320
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
[TBL] [Abstract][Full Text] [Related]
14. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
Huang G; Wang R; Wang D; Zhang Z; Deng S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
[TBL] [Abstract][Full Text] [Related]
15. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
Ebube NK; Jones AB
Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
[TBL] [Abstract][Full Text] [Related]
16. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets.
Siepmann J; Podual K; Sriwongjanya M; Peppas NA; Bodmeier R
J Pharm Sci; 1999 Jan; 88(1):65-72. PubMed ID: 9874704
[TBL] [Abstract][Full Text] [Related]
17. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
Bravo SA; Lamas MC; Salamón CJ
J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
[TBL] [Abstract][Full Text] [Related]
18. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
[TBL] [Abstract][Full Text] [Related]
19. Relationships between the release of soluble drugs from HPMC matrices and the physicochemical properties of drugs.
Fu XC; Liang WQ; Ma WX
Pharmazie; 2003 Mar; 58(3):221-2. PubMed ID: 12685821
[No Abstract] [Full Text] [Related]
20. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
Saravanan M; Sri Nataraj K; Ganesh KS
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
